Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson’s Disease
- 29 March 2017
- book chapter
- Published by Springer Nature
- Vol. 14, 3-30
Abstract
The discovery of LRRK2 mutations as a cause of Parkinson’s disease (PD), including the sporadic late-onset form, established the decisive role of genetics in the field of PD research. Among LRRK2 mutations, the G2019S, mostly lying in a haplotype originating from a common Middle Eastern ancestor, has been identified in different populations worldwide. The G2385R and R1628P variants represent validated risk factors for PD in Asian populations. Here, we describe in detail the origin, the present worldwide epidemiology, and the penetrance of LRRK2 mutations. Furthermore, this chapter aims to characterize other definitely/probably pathogenic mutations and risk variants of LRRK2. Finally, we provide some general guidelines for a LRRK2 genetic testing and counseling. In summary, LRRK2 discovery revolutionized the understanding of PD etiology and laid the foundation for a promising future of genetics in PD research.Keywords
This publication has 183 references indexed in Scilit:
- A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson DiseaseThe American Journal of Human Genetics, 2011
- VPS35 Mutations in Parkinson DiseaseThe American Journal of Human Genetics, 2011
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseMovement Disorders, 2010
- LRRK2 mutations and risk variants in Japanese patients with Parkinson's diseaseMovement Disorders, 2009
- Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spainneurogenetics, 2009
- Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutationsMovement Disorders, 2009
- Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutationsMovement Disorders, 2009
- Genomewide association study for susceptibility genes contributing to familial Parkinson diseaseHuman Genetics, 2008
- Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson DiseaseThe American Journal of Human Genetics, 2008
- Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseAnnals of Neurology, 2007